ConductScience.org, home

Paper3530299

Studies on verapamil in the treatment of essential hypertension: a review.

Midtbø K and 4 others. Br J Clin Pharmacol, 1986. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Studies on verapamil in the treatment of essential hypertension: a review. Papers, record 3530299. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3530299

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Studies on verapamil in the treatment of essential hypertension: a review.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1986
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
1.01
iCite
Revised in PubMed
2019-05-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Midtbø KK
2Hals OO
3Lauve OO
4van der Meer JJ
5Storstein LL

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HypertensionMajor topic
VerapamilMajor topic
Delayed-Action Preparations
Humans
Physical Exertion

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14153535Verapamil in cardiology.Eur J Cardiol1974https://conductscience.org/library/papers/4153535PubMed
2353597The treatment of hypertension with verapamil.N Z Med J1978https://conductscience.org/library/papers/353597PubMed
36102688Drugs and the heart. III. Calcium antagonists.Lancet1980https://conductscience.org/library/papers/6102688PubMed
47004293Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications.Ann Intern Med1980https://conductscience.org/library/papers/7004293PubMed
56587750The role of a slow channel inhibitor, verapamil, in the management of hypertension.Acta Med Scand Suppl1984https://conductscience.org/library/papers/6587750PubMed
67030005Calcium blockade as a therapeutic principle in arterial hypertension. Clinical aspects and experimental studies on isolated vessels from spontaneously hypertensive rats and normotensive man.Acta Pharmacol Toxicol (Copenh)1981https://conductscience.org/library/papers/7030005PubMed
77032825Does it matter how blood pressure is reduced?Clin Sci (Lond)1981https://conductscience.org/library/papers/7032825PubMed
86145299Calcium influx blockers in the treatment of essential hypertension.Acta Med Scand Suppl1984https://conductscience.org/library/papers/6145299PubMed
96587749Hemodynamic effects of verapamil in essential hypertension at rest and during exercise.Acta Med Scand Suppl1984https://conductscience.org/library/papers/6587749PubMed
106108816Haemodynamics in essential hypertension.Clin Sci (Lond)1980https://conductscience.org/library/papers/6108816PubMed

Download CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
38089049Preliminary evaluation of the antiglycoxidant activity of verapamil using various in vitro and in silico biochemical/biophysical methods.Front Pharmacol2023https://conductscience.org/library/papers/38089049PubMed
32431612Verapamil and Alzheimer's Disease: Past, Present, and Future.Front Pharmacol2020https://conductscience.org/library/papers/32431612PubMed
22044933Verapamil results in increased blood levels of oncolytic adenovirus in treatment of patients with advanced cancer.Mol Ther2012https://conductscience.org/library/papers/22044933PubMed
15350150Micro-electrode arrays in cardiac safety pharmacology: a novel tool to study QT interval prolongation.Drug Saf2004https://conductscience.org/library/papers/15350150PubMed
7512483Postinfarct treatment with verapamil. Effect of verapamil in patients with hypertension.Drugs1993https://conductscience.org/library/papers/7512483PubMed
3042360Drug treatment of hypertension.Drugs1988https://conductscience.org/library/papers/3042360PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3530299

GET https://conductscience.org/api/papers/v1/3530299/authors